Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa

Journal of Adolescent Health

Volumn 21, Issue 3, 1997, Pages 179-182

  Harel, Zeev ^a,b   Riggs, Suzanne ^a  

^a BROWN UNIVERSITY   (United States)

^b HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

Adolescents; Anorexia; Estrogen; Osteopenia; Transdermal administration

Indexed keywords

ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS NORGESTIMATE; MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE MINERAL; CASE REPORT; ESTROGEN THERAPY; FEMALE; HUMAN; LUMBAR SPINE; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; OSTEOPENIA; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030746657     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(97)82777-2     Document Type: Article

References (24)

1. Ayers JWT, Gidwani GP, Schmidt IMV, et al. Osteopenia in hypoestrogenic young women with anorexia nervosa. Fertil Steril 1984;41:224-8.
2. Biller BMK, Saxe V, Herzog DB, et al. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989;68:548-54.
3. Bachrach LK, Guido D, Katzman DK, et al. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990;86:440-7.
4. Kiriike N, Iketani T, Nakanishi S, et al. Reduced bone density and major hormones regulating calcium metabolism in anorexia nervosa. Acta Psychiatry Scand 1992;86:358-63.
5. Abrams SA, Silber TJ, Esteban NV, et al. Mineral balance and bone turnover in adolescents with anorexia nervosa. J Pediatr 1993;123:326-31.
6. Bachrach LK, Katzman DK, Litt IF, et al. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 1991;72:602-6.
7. Kreipe RE, Hicks DG, Rosier RN, et al. Preliminary findings on the effects of sex hormones on bone metabolism in anorexia nervosa. J Adolesc Health 1993;14:319-24.
8. Hergenroeder AC. Bone mineralization, hypothalamic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 1995;126:683-9.
9. Klibanski A, Biller BM, Schoenfeld DA, et al. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80:898-904.
10. Ho KK, Weissberger AJ. Impact of short-term estrogen administration on growth hormone secretion and action: Distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 1992;7:821-7.
11. Evans SF, Davie MWJ. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages. Clin Endocrinol 1996;44:79-84.
12. Faulkner RA, Bailey DA, Drinkwater DT, et al. Bone densitometry in Canadian children 8-17 years of age. Calcif Tissue Int 1996;59:344-51.
13. Cisternino M, Bozzola M, Chiara A, et al. Transdermal estradiol substitution therapy for female hypogonadism in thalassemia major. J Pediatr Adolesc Gynecol 1990;3:25-30.
14. Creatsas G, Arefetz N, Adamopoulos PN, et al. Transdermal estradiol plus oral medroxyprogesterone acetate replacement therapy in primary amenorrheic adolescents. Clinical, hormonal, and metabolic aspects. Maturitas 1994;18:105-14.
15. Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biologic effects of transdermal estradiol. N Engl J Med 1986;314:1615-20.
16. Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991;72:374-81.
17. Slowinska-Srzednicka J, Zgliczyn-iki S, Jeske W, et al. Transdermal 17 beta estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor 1 in postmenopausal women. J Endocrinol Invest 1992;15: 533-8.
18. Kelly JJ, Rajkovic IA, O'Sullivan AJ, et al. Effects of different oral estrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 1993;39:561-7.
19. Campagnoli C, Biglia N, Altare F, et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 1993;7: 251-8.
20. Ljunghall S, Lindh E, Johansson AG. Endocrine interactions of insulin-like growth factor I on bone. Acta Paediatr Suppl 1994;399:178-9.
21. Rosen CJ, Donahue LR, Hunter SJ. Insulin-like growth factors and bone: The osteoporosis connection. Proc Soc Exp Biol Med 1994;206:83-102.
22. Hill KK, Hill DB, McClain MP, et al. Serum insulin-like growth factor-I concentrations in the recovery of patients with anorexia nervosa. J Am Coll Nutr 1993;12:475-8.
23. Grey A, Cundy T, Evans M, et al. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women. Clin Endocrinol 1996;44:293-6.
24. Pertzelan A, Yalon L, Kauli R, et al. A comparative study of the effect of oestrogen substitution therapy on breast development in girls with hypo-and hypergonadotrophic hypogonadism. Clin Endocrinol 1982;16:359-68.